Constellation Brands shares rise as Q3 earnings top expectations

Constellation Brands reported fiscal Q3 net sales of $2.22 billion (down 10% YoY; comparable net sales down 2%), beating the $2.18 billion consensus, and delivered comparable EPS of $3.06 (down 6% YoY) versus a $2.65 consensus; reported EPS was $2.88. The beer business outperformed peers in US tracked channels while wine and spirits operating income plunged 65% to $33.7 million. Management updated fiscal 2026 reported EPS guidance to $9.72–$10.02 and reaffirmed comparable EPS of $11.30–$11.60, and forecast operating cash flow of $2.5–$2.6 billion and free cash flow of $1.3–$1.4 billion, driving a >4% intraday share gain.

Analysis

Market structure: Constellation (STZ) is the near-term beneficiary of resilient premium beer demand and premium wine strength, while commodity/value wine producers and discount spirits players face share loss; beer growth outpacing total beverage alcohol by ~0.5ppt (Circana) implies pricing/promo leverage for STZ in US tracked channels over next 2–6 quarters. Retail/distribution winners include large off-premise retailers and beverage wholesalers who carry more premium SKUs; suppliers of premium hops/grains may see modest upside in spot prices if volumes hold.

Risk assessment: Tail risks include excise/tax shocks or state-level restrictions (low-probability, high-impact) and climate-driven grape shortages that could compress wine margins >200–500bps; trigger thresholds to watch: comparable EPS guidance cut >5% or FCF below $1.1b would materially change thesis. Time horizons: immediate (days) volatility around digesting the beat, short-term (3–6 months) execution on cost and inventory, long-term (12–36 months) premiumization and margin recovery in wine/spirits.

Trade implications: Primary trade is a tactical long STZ (1–2% portfolio) on continued beer momentum, paired with a short exposure to a spirits-heavy peer (e.g., BF.B) sized 0.75–1% for relative-value; consider 3–6 month call spreads on STZ (buy 0–10% ITM to 15–25% OTM) if you want asymmetry vs outright stock. Use stop-losses: cut long STZ if comparable EPS guide is lowered by >5% or FCF midpoint misses by >10%.

Contrarian angles: Market may underweight that reported vs comparable EPS divergence ($9.72–10.02 reported vs $11.30–11.60 comparable) hides one-offs—investors focused on reported EPS may overreact. Historical parallels show premium beverage cycles recover in 2–4 quarters after inventory normalization; unintended consequence: aggressive defensive cost cuts in wine/spirits could reduce future top-line premium positioning and slow long-term pricing power.

Key Decisions for Investors

• Establish a 1.5% of portfolio long position in STZ within the next 2–6 weeks, targeting outperformance over 3–6 months; trim or stop-loss if comparable EPS guidance is revised down >5% or FCF midpoint falls below $1.2bn.
• Implement a 0.75–1.0% pair trade: long STZ vs short BF.B (Brown‑Forman Class B) for 3–6 months to capture US beer premiumization vs spirits exposure; rebalance if spread narrows <2% or widens >10% relative to inception.
• Buy a 3–6 month STZ call spread sized to 0.5–1% portfolio: buy 0–10% ITM call and sell 15–25% OTM call to cap cost; target gross return 15–30% and unwind on a >10% pop or ahead of the next earnings release to avoid event volatility.
• Sell covered calls on existing STZ holdings (if yield harvesting) with 1–2 month tenor at ~5% OTM to collect premium; close if implied volatility rises >30% above 60-day average or after a material guidance change.
• Avoid broad wine/large-spirits single-name longs until management provides a clear recovery path; specifically reduce incremental buys of pure-play wine tickers by 30% over the next 90 days unless operating income margins recover by >200bps sequentially.